Serveur d'exploration sur le peuplier

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.

Identifieur interne : 000710 ( Main/Exploration ); précédent : 000709; suivant : 000711

Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.

Auteurs : Gerwyn Morris [Australie] ; Michael Berk [Australie] ; Michael Maes [Australie, Thaïlande] ; André F. Carvalho [Canada] ; Basant K. Puri [Royaume-Uni]

Source :

RBID : pubmed:30685844

Descripteurs français

English descriptors

Abstract

Severe socioeconomic deprivation (SED) and adverse childhood experiences (ACE) are significantly associated with the development in adulthood of (i) enhanced inflammatory status and/or hypothalamic-pituitary-adrenal (HPA) axis dysfunction and (ii) neurological, neuroprogressive, inflammatory and autoimmune diseases. The mechanisms by which these associations take place are detailed. The two sets of consequences are themselves strongly associated, with the first set likely contributing to the second. Mechanisms enabling bidirectional communication between the immune system and the brain are described, including complex signalling pathways facilitated by factors at the level of immune cells. Also detailed are mechanisms underpinning the association between SED, ACE and the genesis of peripheral inflammation, including epigenetic changes to immune system-related gene expression. The duration and magnitude of inflammatory responses can be influenced by genetic factors, including single nucleotide polymorphisms, and by epigenetic factors, whereby pro-inflammatory cytokines, reactive oxygen species, reactive nitrogen species and nuclear factor-κB affect gene DNA methylation and histone acetylation and also induce several microRNAs including miR-155, miR-181b-1 and miR-146a. Adult HPA axis activity is regulated by (i) genetic factors, such as glucocorticoid receptor polymorphisms; (ii) epigenetic factors affecting glucocorticoid receptor function or expression, including the methylation status of alternative promoter regions of NR3C1 and the methylation of FKBP5 and HSD11β2; (iii) chronic inflammation and chronic nitrosative and oxidative stress. Finally, it is shown how severe psychological stress adversely affects mitochondrial structure and functioning and is associated with changes in brain mitochondrial DNA copy number and transcription; mitochondria can act as couriers of childhood stress into adulthood.

DOI: 10.1007/s12035-019-1498-1
PubMed: 30685844
PubMed Central: PMC6614134


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.</title>
<author>
<name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
<affiliation wicri:level="1">
<nlm:affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<affiliation wicri:level="1">
<nlm:affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Psychiatry, Level 1 North, Main Block, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Psychiatry, Level 1 North, Main Block, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, 30 Royal Parade, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, 30 Royal Parade, Parkville, Victoria</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
<affiliation wicri:level="1">
<nlm:affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Department of Psychiatry, Chulalongkorn University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Carvalho, Andre F" sort="Carvalho, Andre F" uniqKey="Carvalho A" first="André F" last="Carvalho">André F. Carvalho</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre for Addiction & Mental Health (CAMH), Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Puri, Basant K" sort="Puri, Basant K" uniqKey="Puri B" first="Basant K" last="Puri">Basant K. Puri</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK. basant.puri@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Medicine, Hammersmith Hospital, Imperial College London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30685844</idno>
<idno type="pmid">30685844</idno>
<idno type="doi">10.1007/s12035-019-1498-1</idno>
<idno type="pmc">PMC6614134</idno>
<idno type="wicri:Area/Main/Corpus">000A62</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A62</idno>
<idno type="wicri:Area/Main/Curation">000A62</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000A62</idno>
<idno type="wicri:Area/Main/Exploration">000A62</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.</title>
<author>
<name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
<affiliation wicri:level="1">
<nlm:affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<affiliation wicri:level="1">
<nlm:affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Psychiatry, Level 1 North, Main Block, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Psychiatry, Level 1 North, Main Block, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, 30 Royal Parade, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, 30 Royal Parade, Parkville, Victoria</wicri:regionArea>
<orgName type="university">Université de Melbourne</orgName>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
<affiliation wicri:level="1">
<nlm:affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Department of Psychiatry, Chulalongkorn University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Carvalho, Andre F" sort="Carvalho, Andre F" uniqKey="Carvalho A" first="André F" last="Carvalho">André F. Carvalho</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre for Addiction & Mental Health (CAMH), Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Puri, Basant K" sort="Puri, Basant K" uniqKey="Puri B" first="Basant K" last="Puri">Basant K. Puri</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK. basant.puri@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Medicine, Hammersmith Hospital, Imperial College London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Molecular neurobiology</title>
<idno type="eISSN">1559-1182</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Adverse Childhood Experiences (MeSH)</term>
<term>Brain (pathology)</term>
<term>Disease (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immune System (pathology)</term>
<term>Inflammation (pathology)</term>
<term>Socioeconomic Factors (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Encéphale (anatomopathologie)</term>
<term>Expériences défavorables de l'enfance (MeSH)</term>
<term>Facteurs socioéconomiques (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Inflammation (anatomopathologie)</term>
<term>Maladie (MeSH)</term>
<term>Système immunitaire (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Encéphale</term>
<term>Inflammation</term>
<term>Système immunitaire</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain</term>
<term>Immune System</term>
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Adverse Childhood Experiences</term>
<term>Disease</term>
<term>Humans</term>
<term>Socioeconomic Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Expériences défavorables de l'enfance</term>
<term>Facteurs socioéconomiques</term>
<term>Humains</term>
<term>Maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Severe socioeconomic deprivation (SED) and adverse childhood experiences (ACE) are significantly associated with the development in adulthood of (i) enhanced inflammatory status and/or hypothalamic-pituitary-adrenal (HPA) axis dysfunction and (ii) neurological, neuroprogressive, inflammatory and autoimmune diseases. The mechanisms by which these associations take place are detailed. The two sets of consequences are themselves strongly associated, with the first set likely contributing to the second. Mechanisms enabling bidirectional communication between the immune system and the brain are described, including complex signalling pathways facilitated by factors at the level of immune cells. Also detailed are mechanisms underpinning the association between SED, ACE and the genesis of peripheral inflammation, including epigenetic changes to immune system-related gene expression. The duration and magnitude of inflammatory responses can be influenced by genetic factors, including single nucleotide polymorphisms, and by epigenetic factors, whereby pro-inflammatory cytokines, reactive oxygen species, reactive nitrogen species and nuclear factor-κB affect gene DNA methylation and histone acetylation and also induce several microRNAs including miR-155, miR-181b-1 and miR-146a. Adult HPA axis activity is regulated by (i) genetic factors, such as glucocorticoid receptor polymorphisms; (ii) epigenetic factors affecting glucocorticoid receptor function or expression, including the methylation status of alternative promoter regions of NR3C1 and the methylation of FKBP5 and HSD11β2; (iii) chronic inflammation and chronic nitrosative and oxidative stress. Finally, it is shown how severe psychological stress adversely affects mitochondrial structure and functioning and is associated with changes in brain mitochondrial DNA copy number and transcription; mitochondria can act as couriers of childhood stress into adulthood.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30685844</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>12</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1559-1182</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>56</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2019</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Molecular neurobiology</Title>
<ISOAbbreviation>Mol Neurobiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.</ArticleTitle>
<Pagination>
<MedlinePgn>5866-5890</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-019-1498-1</ELocationID>
<Abstract>
<AbstractText>Severe socioeconomic deprivation (SED) and adverse childhood experiences (ACE) are significantly associated with the development in adulthood of (i) enhanced inflammatory status and/or hypothalamic-pituitary-adrenal (HPA) axis dysfunction and (ii) neurological, neuroprogressive, inflammatory and autoimmune diseases. The mechanisms by which these associations take place are detailed. The two sets of consequences are themselves strongly associated, with the first set likely contributing to the second. Mechanisms enabling bidirectional communication between the immune system and the brain are described, including complex signalling pathways facilitated by factors at the level of immune cells. Also detailed are mechanisms underpinning the association between SED, ACE and the genesis of peripheral inflammation, including epigenetic changes to immune system-related gene expression. The duration and magnitude of inflammatory responses can be influenced by genetic factors, including single nucleotide polymorphisms, and by epigenetic factors, whereby pro-inflammatory cytokines, reactive oxygen species, reactive nitrogen species and nuclear factor-κB affect gene DNA methylation and histone acetylation and also induce several microRNAs including miR-155, miR-181b-1 and miR-146a. Adult HPA axis activity is regulated by (i) genetic factors, such as glucocorticoid receptor polymorphisms; (ii) epigenetic factors affecting glucocorticoid receptor function or expression, including the methylation status of alternative promoter regions of NR3C1 and the methylation of FKBP5 and HSD11β2; (iii) chronic inflammation and chronic nitrosative and oxidative stress. Finally, it is shown how severe psychological stress adversely affects mitochondrial structure and functioning and is associated with changes in brain mitochondrial DNA copy number and transcription; mitochondria can act as couriers of childhood stress into adulthood.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Morris</LastName>
<ForeName>Gerwyn</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berk</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Level 1 North, Main Block, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, 30 Royal Parade, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maes</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, P.O. Box 291, Geelong, Victoria, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carvalho</LastName>
<ForeName>André F</ForeName>
<Initials>AF</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Puri</LastName>
<ForeName>Basant K</ForeName>
<Initials>BK</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-6101-0139</Identifier>
<AffiliationInfo>
<Affiliation>Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK. basant.puri@imperial.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>01</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Neurobiol</MedlineTA>
<NlmUniqueID>8900963</NlmUniqueID>
<ISSNLinking>0893-7648</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000076783" MajorTopicYN="Y">Adverse Childhood Experiences</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004194" MajorTopicYN="Y">Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012959" MajorTopicYN="Y">Socioeconomic Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adverse childhood experiences</Keyword>
<Keyword MajorTopicYN="N">Gene expression</Keyword>
<Keyword MajorTopicYN="N">Hypothalamic–pituitary–adrenal axis</Keyword>
<Keyword MajorTopicYN="N">Immune system</Keyword>
<Keyword MajorTopicYN="N">Mitochondria</Keyword>
<Keyword MajorTopicYN="N">Socioeconomic deprivation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>11</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>01</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>1</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>1</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30685844</ArticleId>
<ArticleId IdType="doi">10.1007/s12035-019-1498-1</ArticleId>
<ArticleId IdType="pii">10.1007/s12035-019-1498-1</ArticleId>
<ArticleId IdType="pmc">PMC6614134</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 1999;461:107-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10442170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Baillieres Best Pract Res Clin Rheumatol. 1999 Dec;13(4):599-613</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10652642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Lett. 2000 Nov 20;117(3):151-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11087981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2001 Apr;24(4):420-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11182537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Auton Neurosci. 2000 Dec 20;85(1-3):49-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11189026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrine. 2000 Dec;13(3):369-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11216650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6865-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11381138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2001 Aug;57(2):139-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11461161</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2002 May;143(5):1571-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11956136</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2002 Apr;31(2):285-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11980781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2002 May 2;417(6884):87-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11986670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2002 Jun;966:39-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12114257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biochem. 2002 May-Jun;234-235(1-2):239-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12162440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroendocrinol. 2002 Nov;14(11):911-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12421345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Jan 23;421(6921):384-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12508119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2003 Jun 1;187(11):1679-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12751024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Pathol. 2003 Jul;56(7):481-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12835292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Epidemiol Community Health. 2003 Sep;57(9):730-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12933781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 1992 Nov;19(11):1692-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1337108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cardiol. 2003 Oct 15;92(8):984-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14556880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2004 Jan 1;13(1):47-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14583441</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2003 Nov-Dec;65(6):984-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14645776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Psychiatry. 2004 Jan;9(1):65-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14699442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Immun. 2004 Mar;5(2):122-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14737096</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Recent Prog Horm Res. 2004;59:333-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14749509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetologia. 2004 Jun;47(6):1088-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15156315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Med. 2004 Apr;34(3):509-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15259836</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Pharmacol. 2004 Sep 15;68(6):1255-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15313424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol Pharmacol. 2004 Dec;55(4):679-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15613736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2004 Nov;32(11):2304-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15640646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):68-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15703509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 2005 Mar;160(1-2):87-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15710461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viral Immunol. 2005;18(1):41-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15802953</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Brain Res Rev. 2005 Apr;48(2):302-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15850669</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinol Metab Clin North Am. 2005 Jun;34(2):271-92, vii</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15850842</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2005 Oct 20;353(16):1711-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16236742</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Res. 2006;55(4):453-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16238459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 2006 Feb;171(1-2):72-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16278020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Res. 2007 Jan-Feb;41(1-2):152-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16375926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2006 Apr 1;163(7):622-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16421236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):284-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16567379</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 1991 Dec;73(6):1224-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1659582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Allergy Clin Immunol. 2006 May;117(5):1014-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16675327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neuroendocrinol. 2006 Sep;27(3):275-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16814372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2006 Sep;163(9):1630-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16946190</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 1991 Jan;128(1):623-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1702707</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol Pharmacol. 2006 Sep;57(3):463-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17033098</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2007 Jan;148(1):386-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17038555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2007 Jan;21(1):9-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17070667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroinflammation. 2006 Nov 09;3:30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17094809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2007 Jan;35(1):26-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17095945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2006 Nov 27;166(21):2356-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17130389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurobiol Aging. 2008 May;29(5):716-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17184882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2006 Nov;1088:41-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17192555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Epidemiol. 2007;22(1):55-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17225957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1319-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17229839</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17242365</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2006 Dec;34(3):221-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17308354</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):45-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17336577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Mol Cell Biol. 2007 Apr;8(4):307-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17342184</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinol Metab Clin North Am. 2007 Jun;36(2):521-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17543733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Endocrinol. 2007 Sep 15;275(1-2):13-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17689856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2007 Oct 15;62(8):863-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17716631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Sci. 2007 Nov;18(11):953-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17958708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2007 Nov 20;116(21):2383-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18025402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hypertension. 2008 Feb;51(2):211-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18086956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2008 Jan 14;168(1):33-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18195193</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Jan 31;358(5):453-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18234750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pharmacol. 2008 Apr 7;583(2-3):303-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18321483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Prev Med. 2008 May;34(5):396-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18407006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2008 Aug 15;64(4):266-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18440494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Z Rheumatol. 2008 Jul;67(4):315-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18491117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Neurosci. 2008 May;27(10):2701-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18513320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Jul 3;359(1):61-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18596274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Immunol. 2008 Mar-Apr;252(1-2):1-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18619587</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Leukoc Biol. 2008 Oct;84(4):924-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18664528</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroimmunomodulation. 2008;15(1):19-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18667796</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroimmunomodulation. 2008;15(1):37-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18667798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2008 Nov 14;283(46):31315-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18801740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Cancer. 2008 Nov;8(11):887-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18846100</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cardiol. 2008 Oct 15;102(8):1034-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18929705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurochem Int. 2008 Dec;53(6-8):395-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18940214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2009 May;1787(5):431-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19100710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2009 May;150(5):2220-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19131573</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2009 Feb;71(2):243-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19188532</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Anaesth. 2009 Apr;102(4):453-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19258380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 May 22;324(5930):1076-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19461003</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2009 Jun;9(6):418-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19461672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurosci. 2009 Jun;10(6):397-409</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19469025</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2009 Jun 3;301(21):2252-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19491187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine Growth Factor Rev. 2009 Jun;20(3):223-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19502097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Soc Sci Med. 2009 Aug;69(3):451-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19524346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2009 Aug 15;66(4):384-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19559404</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2009 Oct;73(4):531-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19570616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 2009 Sep;29(17):4788-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19581287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14716-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19617551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2009 Oct;38(5):1297-309</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19720725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Commun Integr Biol. 2009 Jul;2(4):350-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19721888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IUBMB Life. 2009 Oct;61(10):979-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19787703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Affect Disord. 2010 Jun;123(1-3):52-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19853306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2010 Mar;85(3):463-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19857525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Cancer Inst. 2009 Nov 4;101(21):1489-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19861305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2009 Nov;60(11):3303-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19877066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2009 Oct;1179:86-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19906234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2009 Oct;1179:167-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19906239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2009 Oct;1179:179-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19906240</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2009 Oct;1179:199-215</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19906241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CNS Neurol Disord Drug Targets. 2010 Jul;9(3):373-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20053169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Neurobiol. 2010 Jul;30(5):693-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20063054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mutat Res. 2010 Aug 7;690(1-2):108-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20109474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2010 Oct;24(7):1058-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20153418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2010 Aug 15;13(4):489-509</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20210649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Scand J Immunol. 2010 Apr;71(4):227-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20384865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Sci. 2010 Jan;21(1):31-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20424019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Soc Sci Med. 2010 Jul;71(1):187-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20430502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Sci. 2010 Jun;21(6):848-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20431047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2010 Oct;35(9):1410-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20444551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Epidemiol Community Health. 2010 May;64(5):413-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20445210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2010 Aug 27;39(4):493-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20797623</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wiley Interdiscip Rev Syst Biol Med. 2010 May-Jun;2(3):362-371</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20836034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2010 Dec 10;285(50):38951-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20937840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Neuropsychopharmacol. 2011 Jun;21(6):471-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20965701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomed Biotechnol. 2010;2010:302693</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21052548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Prev Med. 2010 Dec;39(6):529-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21084073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Cell Biol. 2011 Jun;3(3):159-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21502305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2011 May 25;31(21):7579-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21613472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Regul. 2011 Apr;45(2):91-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21615193</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2012 Jan;37(1):65-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21641728</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2011 Oct;1813(10):1814-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21664385</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2011 Oct;25(7):1468-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21672624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stress. 2011 Nov;14(6):614-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21675865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2011 Aug 1;71(15):5214-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21690566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2011 Dec 1;70(11):1074-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21791337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2011 Aug 19;333(6045):982-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21852492</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2011 Oct 7;334(6052):98-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21921156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2011 Nov 4;286(44):38703-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21940629</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Traffic. 2012 Mar;13(3):364-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21951602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2012 Jun;37(6):782-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21978868</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2012 Feb;26(2):337-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22041296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurosci. 2011 Nov 30;13(1):22-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22127301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2011 Dec 08;2:e240</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22158479</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interferon Cytokine Res. 2012 Apr;32(4):139-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22191464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2011 Dec;1243:88-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22211895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2012 Jul;37(7):1057-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22244747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2012 Feb;41(1):62-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22422449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5995-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22474371</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Public Health. 2013 Feb;58(1):3-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22588310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Neurosci. 2012 Oct;122(10):583-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22591409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2012 Jun;122(6):1973-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22622040</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glia. 2013 Jan;61(1):71-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22674585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2013 Feb;38(2):188-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22727478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2013 Apr 20;18(12):1475-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22746161</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Lipid Res. 2012 Sep;53(9):2002-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22766885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2013 Jan;27(1):8-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22771426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2013 Mar;38(3):331-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22809790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Ther Med. 2012 Feb;4(2):237-242</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22844350</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2012 Nov;79(5):607-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22951418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epigenetics. 2012 Nov;7(11):1290-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23023726</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17253-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23045638</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Psychopathol. 2012 Nov;24(4):1417-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23062307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurol Sci. 2013 Jul;34(7):1167-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23064802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurobiol Aging. 2013 Apr;34(4):1069-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23141413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cells. 2013 Jan;35(1):17-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23212344</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Endocrinol. 2013 Nov 5;380(1-2):41-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23267834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autoimmun. 2013 Mar;41:111-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23395552</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Res. 2013 May;47(5):604-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23415658</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2013 Aug;48(1):190-204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23436141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Neuropsychopharmacol. 2013 Aug;16(7):1513-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23449091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2013 Nov 1;19(13):1522-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23477488</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2013 Mar 08;11:64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23497361</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interferon Cytokine Res. 2013 Sep;33(9):467-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23675778</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2013 Oct;38(10):2127-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23684478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Genomics. 2012 Dec;13(8):633-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23730203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care. 2013 Jun 12;17(3):R107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23759144</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Inorg Biochem. 2013 Nov;128:267-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23778113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Neuropathol. 2013 Aug;126(2):237-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23812288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharm Bioallied Sci. 2013 Apr;5(2):91-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23833514</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2013;10(7):e1001479</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23843750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2013 Nov;38(11):2405-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23916911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Aug 19;8(8):e71691</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23977113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Physiol. 2014 Jan;99(1):62-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24036596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Sep 09;8(9):e73689</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24040027</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrients. 2013 Sep 23;5(9):3757-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24064574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2013 Sep 26;155(1):242-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24074872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Methods. 2013 Oct;10(10):949-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24076989</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain. 2014 Feb;137(Pt 2):354-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24163249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Epidemiol. 2013 Dec;23(12):797-811.e2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24184029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neurosci. 2013 Oct 29;7:204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24194696</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Gerontol. 2014 Jan;49:19-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24212137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Traffic. 2014 Feb;15(2):127-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24289861</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroscience. 2014 Apr 4;264:157-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24333971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epigenetics. 2014 Mar;9(3):333-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24394602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biochem Cell Biol. 2014 Apr;49:26-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24412630</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Lett. 2014 Mar 21;225(3):488-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24440346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropharmacology. 2014 May;80:115-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24452011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Med. 2014 Apr;33(4):817-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24535292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Rep. 2013;65(6):1655-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24553014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroinflammation. 2014 Feb 24;11:34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24565378</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2014 Feb 25;5:71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24611065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Endocrinol. 2014 May;10(5):303-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24663223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neuropharmacol. 2014 Mar;12(2):168-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24669210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2014 Aug;155(8):2942-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24693964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2014 Mar 31;5:136</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24744759</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2014 May 23;448(1):101-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24769202</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2014 Apr 07;5:143</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24778633</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Psychol. 2014 Nov;33(11):1430-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24818608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biochem Cell Biol. 2014 Aug;53:246-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24880090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Musculoskelet Disord. 2014 Jul 09;15:227</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25007969</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Psychiatry. 2014 Aug 12;14:232</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25113244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Diabetes. 2014 Aug 15;5(4):493-504</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25126395</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurosci. 2012 Jan;19(1):40-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25205962</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2014 Oct;41:191-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25242587</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neuroendocrinol. 2015 Jan;36:150-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25256348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Neurobiol. 2015;10:61-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25287536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15232-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288769</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Oct 13;9(10):e108426</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25309988</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Reumatol Port. 2014 Jul-Sep;39(3):218-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25326402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Connect. 2015 Mar;4(1):R1-R15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25385852</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2015 Jan;51:403-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25462912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prev Med. 2015 Feb;71:12-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25482420</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neurosci. 2014 Nov 21;8:369</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25484853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Neuropsychopharmacol. 2014 Dec 13;18(4):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25522420</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroendocrinol. 2015 Jun;27(6):487-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25546497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2016 Mar;53(2):1195-219</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25598355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neurosci. 2015 Jan 19;8:456</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25646076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Psychiatry. 2015 Feb 05;15:15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25652365</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Soc Sci Med. 2015 Apr;130:16-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25658624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2016 Jan 15;79(2):87-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25687413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2015 Feb 03;6:43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25691883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Behav. 2015 Oct 15;150:2-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25701594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroendocrinol. 2015 Jun;27(6):498-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25737228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2015 Apr 9;161(2):387-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25772697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Res Ther. 2015 Jan 28;17:15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25774937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Mol Neurosci. 2015 Mar 02;8:5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25784854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L1078-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25795724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CNS Neurol Disord Drug Targets. 2015;14(7):838-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25801843</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mediators Inflamm. 2015;2015:201703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25814785</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2015 Feb 06;13:28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25856766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2015 Apr 01;13:68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25889215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Psychiatry. 2016 May;21(5):642-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26033244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Biobehav Rev. 2015 Aug;55:520-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26073068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol Pharmacol. 2015 Jun;66(3):427-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26084225</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2015 Jun 18;6:e1793</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26086966</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Res Int. 2015;2015:797280</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26106615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epigenomics. 2015;7(4):593-608</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26111031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Indian J Psychiatry. 2015 Apr-Jun;57(2):218</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26124535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Brain. 2015 Jul 02;8:40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26135882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2016 Apr;45(2):343-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26163255</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Neurosci. 2015 Aug;38(8):468-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26187720</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2016 Jan;41(1):261-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26250598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epigenetics. 2015;10(10):958-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26295359</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2016 Sep 1;80(5):372-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26410355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Sep 29;10(9):e0138929</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26418562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Australas Psychiatry. 2015 Dec;23(6):644-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26432654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):E6614-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26627253</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Atherosclerosis. 2016 Jan;244:211-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26687466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2016 Jan;16(1):22-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26711676</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2016 Apr;78(3):311-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26716815</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2016 Jan 21;61(2):199-209</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26725009</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Mol Neurosci. 2015 Dec 18;8:77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26733801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2016 Apr;78(3):290-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26734956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Biol. 2016 Jan 13;17:4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26758199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2016 Apr;66:56-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26773401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Epigenetics. 2016 Jan 28;8:12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26823689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Lett. 2016 Mar 23;617:173-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26845563</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2016 May;233(9):1637-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26847047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Feb 18;6:20926</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26887636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroendocrinology. 2017;104(1):72-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26895241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2016 May;67:182-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26923848</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Cell Biol. 2016 Aug;94(7):631-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26924642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gerontol B Psychol Sci Soc Sci. 2016 Nov;71(6):1097-1107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26926957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Sex Abus. 2016;25(2):175-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26934543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26979502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Pediatr. 2016 Jun;28(3):281-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27043086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2016 Sep;41(10):2530-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27091381</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Apr 27;6:25170</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27117519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Basic Res Cardiol. 2016 Jul;111(4):42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27164906</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Genet. 2016 Jun 23;12(6):e1006105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27336614</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Med. 2016 Jul 19;8(1):76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27435189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9099-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27457949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2016 Jul 27;36(30):7946-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27466339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Endocrinol (Lausanne). 2016 Jul 29;7:106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27524977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mitochondrion. 2016 Sep;30:197-207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27530300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Hum Neurosci. 2016 Aug 09;10:398</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27555812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Epigenetics. 2016 Sep 06;8:92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27602172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2017 Jan;42(1):318-333</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27604565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2016;22(40):6058-6075</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27634186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Sep 21;6:33820</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27650680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Neurosci. 2016 Dec;77:53-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27729244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2017 Nov;54(9):6806-6819</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27766535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2016 Nov 3;167(4):1099-1110.e14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27814507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2016 Nov 3;167(4):1125-1136.e8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27814509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JCI Insight. 2016 Nov 17;1(19):e87748</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27882346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transl Psychiatry. 2016 Dec 6;6(12):e971</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27922635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Biol. 2016 Dec 12;17(1):255</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27955697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Psychiatr Scand. 2017 May;135(5):373-387</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28122130</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2017 Mar 8;12(3):e0173270</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28273124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Cell Biol. 2017 Jun;27(6):453-463</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28274652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2017 Mar 15;12(3):e0173826</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28296938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EBioMedicine. 2017 Apr;18:327-350</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28434943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Psychiatry. 2017 Jun 1;74(6):551-552</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28445556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mediators Inflamm. 2017;2017:7848591</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28490839</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Synaptic Neurosci. 2017 May 10;9:9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28539882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2017 Dec 1;186(11):1227-1236</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28595325</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Brain Behav. 2018 Mar;17(3):e12423</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28873274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2018 Jul;55(7):5767-5786</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29052145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 2018 Jan 1;192:26-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29155300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neuroendocrinol. 2018 Apr;49:72-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29339091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2018 Feb/Mar;80(2):141-153</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29389736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Metab Brain Dis. 2018 Aug;33(4):1081-1096</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29542039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2018 Jul;43(8):1706-1711</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29728648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2018 May 04;9:832</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29780380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Psychiatry. 2018 May 25;18(1):149</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29801445</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Immunol. 2018 Oct;195:139-148</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29894743</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neuropsychiatry. 2018 Jun;4(1):52-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29998118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2019 Apr;56(4):2590-2605</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30047100</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Psychiatry. 2018 Aug 06;9:354</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30127754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomol Concepts. 2018 Nov 20;9(1):115-130</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30471214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 1973 Sep;93(3):619-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4146482</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 1993 Nov;61(5):1957-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7901339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 1994 Oct;79(4):1212-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7962296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 1993 May;60(5):1650-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8097232</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroimmunomodulation. 1994 Jan;1(1):14-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8528879</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain. 1997 Jun;120 ( Pt 6):1067-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9217689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 1998 Sep 1;18(17):6662-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9712638</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Pharmacol. 1999 Feb;55(2):317-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9927624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Canada</li>
<li>Royaume-Uni</li>
<li>Thaïlande</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
<li>Ontario</li>
<li>Victoria (État)</li>
</region>
<settlement>
<li>Londres</li>
<li>Melbourne</li>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Melbourne</li>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
</noRegion>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</country>
<country name="Thaïlande">
<noRegion>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</noRegion>
</country>
<country name="Canada">
<region name="Ontario">
<name sortKey="Carvalho, Andre F" sort="Carvalho, Andre F" uniqKey="Carvalho A" first="André F" last="Carvalho">André F. Carvalho</name>
</region>
<name sortKey="Carvalho, Andre F" sort="Carvalho, Andre F" uniqKey="Carvalho A" first="André F" last="Carvalho">André F. Carvalho</name>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Puri, Basant K" sort="Puri, Basant K" uniqKey="Puri B" first="Basant K" last="Puri">Basant K. Puri</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000710 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000710 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30685844
   |texte=   Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30685844" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020